**No at 87% reflects the absence of any novel pathogen showing sustained human-to-human transmission capable of triggering a WHO-declared pandemic emergency before late 2028.** Current surveillance from CDC, WHO, and ECDC shows the dominant active outbreak—Bundibugyo Ebola in the DRC, now exceeding 10,000 confirmed cases and roughly 5,000 deaths since May 2026—remains regionally contained despite PHEIC status, with only limited imported cases and no efficient airborne spread. H5N1 avian influenza continues animal spillover with sporadic human infections but zero documented sustained human transmission. The 2026–2027 respiratory season outlook projects hospitalization burdens from COVID-19, influenza, and RSV comparable to recent seasons, without signals of immune-evading variants or antigenic shifts that would drive pandemic-scale growth. Post-COVID investments in genomic surveillance, contact tracing, and rapid vaccine platforms have lowered the probability of undetected emergence and uncontrolled expansion within the compressed 14-month window.